Bristol-Myers Squibb Co
SWB:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
SWB:BRM
|
US |
|
FVCBankcorp Inc
NASDAQ:FVCB
|
US |
|
I
|
Illumina Inc
XMUN:ILU
|
US |
|
Haitong Securities Co Ltd
OTC:HTNGF
|
CN |
|
Delivery Hero SE
F:DHER
|
DE |
|
A
|
Akamai Technologies Inc
XMUN:AK3
|
US |
|
Datatec Ltd
OTC:DTTLF
|
ZA |
|
N
|
National Bank of Canada
OTC:NTIOF
|
CA |
|
Bright Horizons Family Solutions Inc
NYSE:BFAM
|
US |
|
Hartadinata Abadi Tbk PT
IDX:HRTA
|
ID |
|
H
|
HSBC Holdings PLC
DUS:HBC1
|
UK |
|
P
|
Park Hotels & Resorts Inc
F:HIP
|
US |
|
M
|
McCormick & Company Inc
BMV:MKCV
|
US |
|
I
|
Informa PLC
OTC:IFJPY
|
UK |
Wall St Price Targets
BRM Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for BRM is 54.979 EUR with a low forecast of 29.092 EUR and a high forecast of 68.53 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BRM's stock price target?
Price Target
54.979
EUR
According to Wall Street analysts, the average 1-year price target for BRM is 54.979 EUR with a low forecast of 29.092 EUR and a high forecast of 68.53 EUR.
What is the Revenue forecast for Bristol-Myers Squibb Co?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is -5%.
What is the Gross Profit forecast for Bristol-Myers Squibb Co?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is -5%.
What is the Operating Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is -5%.
What is the Pre-Tax Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 17%.
